Coordinating Federal Research (PC-CARE Act) With a multitude of federal agencies conducting prostate cancer research, it is vital that everyone is working together to ensure that funding is used in the most efficient way possible. The PC-CARE ActThe Prostate Cancer Community Assistance, Research and Education Act of 2023, or the PC-CARE Act, would establish a committee to monitor, coordinate, and evaluate the activities of all federal agencies involved in prostate cancer research programs. These agencies range from the National Institutes of Health to the Department of Defense. It also brings in smaller agencies, such as the Centers for Medicare and Medicaid Services.Vitally, it gives the private sector a seat at the table. Researchers, patients, clinicians, patient advocates and professional medical societies will all be working with the federal government to ensure that research gaps are being filled and prioritizing the most critical work. Coordinating Stakeholders PC-CARE Act This printable summary infographic explains how the PC-CARE Act functions, and how it can make maximize the funds already allocated to research across the government. View the 1-Pager The PC-CARE Act has been introduced as H.R. 1315 by Representative Greg Murphy from North Carolina. To ask your Member of Congress to cosponsor this bill, click on the button below.